If you weren't familiar with the term "clinical trials" before Covid-19 rocked our worlds, for sure you've heard it by now. Lesser known -- but equally…
When it comes to developing new medicines for Duchenne, creating good drugs is of course paramount. It is also critical, however, to design good trials…
Goal: improve future decision-making in the selection of drugs to advance to clinical trials in Duchenne muscular dystrophy President and COO Laura with our partners…
Innovative device could power smaller, faster trials for Duchenne muscular dystrophy and open clinical trial participation to broader range of patients A key focus…
Today, we are grateful and encouraged to announce that three of our partner organizations are throwing their weight — and some serious financial firepower —…
Last week, The New York Times ran this article about Duchenne. The story mentions the incredible breakthroughs that are currently taking place in the field, but it also highlights…
We recently launched one of our biggest and most important initiatives: The Duchenne Program at UMass Medical School. This brand-new clinic provides coordinated, comprehensive care…